Company intelligence / Profile preview

NT Holding

Wilmington, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

NT Holding Company, operating as NeuroTherm, was a leading developer and manufacturer of medical devices focused on interventional pain management. The company specialized in radiofrequency (RF) ablation technology, providing generators and consumable electrodes used to treat chronic pain by interrupting pain signals. Headquartered in Wilmington, Massachusetts, NeuroTherm was acquired by St. Jude Medical in 2014 to bolster its neuromodulation portfolio. Today, its technologies are part of Abbott Laboratories' chronic pain management offerings, following Abbott's acquisition of St. Jude Medical in 2017.

Therapeutic areas: RheumatologyNeurology
Modalities: DeviceRadiofrequency ablation
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on NT Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NT Holding.

Explore the full profile